228
Views
17
CrossRef citations to date
0
Altmetric
Hyperandrogenism

The prevalence of non-classic adrenal hyperplasia among Turkish women with hyperandrogenism

, , , , , , , , , , , , , & show all
Pages 139-143 | Received 15 Mar 2009, Accepted 20 Jul 2009, Published online: 15 Jan 2010

References

  • Speiser PW, White PC. Congenital adrenal hyperplasia. N Engl J Med 2003;349:776–778.
  • Dewailly D. Nonclassic 21-hydroxylase deficiency. Semin Reprod Med 2002;20:243–248.
  • New MI. Nonclassical 21-hydroxylase deficiency. J Clin Endocrinol Metab 2006;91:4205–4214.
  • Unluhizarci K, Gokce C, Atmaca H, Bayram F, Kelestimur F. A detailed investigation of hirsutism in a Turkish population: idiopathic hyperandrogenemia as a perplexing issue. Exp Clin Endocrinol Diab 2004;112:504–509.
  • Dolzan V, Prezelj J, Vidan-Jeras B, Breskvar K. Adrenal 21-hydroxylase gene mutations in Sloveneian hyperandrogenic women: evaluation of corticotrophin stimulation and HLA polymorphisms in screening for carrier status. Eur J Endocrinol 1999;141:132–139.
  • Speiser PW, Dupont B, Rubinstein P, Plaza A, New MI. High frequency of nonclassical steroid 21 hydroxylase deficiency. Am J Hum Genet 1985;37:650–667.
  • Dumic M, Brkljacic L, Speiser PW, Wood E, Crawford C, Plavsic V, Banicevic M, Radmanovic S, Radica A, Kastelan A, et al An update on the frequency of nonclassic deficiency of adrenal 21 hydroxylase in the Yougoslav population. Acta Endocrinol 1990;122:703–710.
  • Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology and management. Am J Obstet Gynecol 1981;140:815–830.
  • The Rotterdam ESHRE/ASRM-Sponsered PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19–25.
  • Admoni O, Israel S, Lavi I, Gur M, Tenenbaum-Rakover Y. Hyperandrogenism in carriers of CYP21 mutations: the role of genotype. Clin Endocrinol 2006;64:645–651.
  • Azziz R. The evaluation and management of hirsutism. Obstet Gynecol 2003;101:995–1007.
  • Azziz R, Zacur A. 21-hydroxylase deficiency in female hyperandrogenism: screening and diagnosis. J Clin Endocrinol Metab 1989;69:577–584.
  • Chetkowsky RJ, Defazio J, Shamonki I, Judd HL, Chang RJ. The incidence of late-onset congenital adrenal hyperplasia due to 21-hydroxylase deficiency among hirsute women. J Clin Endocrinol Metab 1984;58:595–598.
  • Kuttenn F, Couillin P, Girard F, Billaud L, Vincens M, Boucekkine C, Thalabard JC, Maudelonde T, Spritzer P, Mowszowicz I, et al Late-onset adrenal hyperplasia in hirsutism. N Engl J Med 1985;313:224–231.
  • Aziz R, Sanchez LA, Knochenhauer ES, Moran C, Lorenby J, Stephens KC, Taylor X, Boots LR. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 2004;89:453–462.
  • Speiser P, Knochenhauer E, Dewailly D, Fruzzetti F, Marcondes J, Aziz R. A multicenter study of women with nonclassical congenital adrenal hyperplasia: relationship between genotype and phenotype. Mol Genet Metab 2000;71:527–534.
  • Kamel N, Tonyukuk V, Emral R, Corapcioglu D, Bastemir M, Gullu S. The prevalence of late onset congenital adrenal hyperplasia in hirsute women from Central Anatolia. Endocr J 2003;50:815–823.
  • Yarman S, Dursun A, Oguz F, Alagol F. The prevalence, molecular analysis and HLA typing of late-onset 21-hydroxylase deficiency in Turkish woman with hirsutism and polycystic ovary. Endocr J 2004;51:31–36.
  • Escobar-Morreale H, Sanchon R, San Millan JL. A prospective study of the prevalence of nonclassic congenital adrenal hyperplasia (NCAH) among women presenting with hyperandrogenic symptoms and signs. J Clin Endocrinol Metab 2008;93:527–533.
  • Fanta M, Cibula D, Vrbikova J. Prevalence of nonclassical adrenal hyperplasia (NCAH) in hyperandrogenic women. Gynecol Endocrinol 2008;24:154–157.
  • Trakakis E, Rizos D, Loghis C, Chryssikopoulos M, Salamaleksi E, Simeonides G, Vagopoulos P, Salamalekis G, Kassanos D. The prevalence of non-classic adrenal hyperplasia due to 21-hydroxylase deficiency in Greek women with hirsutism and polycystic ovary syndrome. Endocr J 2008;55:33–39.
  • Moran C, Azziz R, Carmina E, Dewailly D, Fruzzetti F, Ibanez L, Knochenhauer ES, Marcondes JAM, Mendonca BB, Pignatelli D, et al 21-hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study. Am J Obstet Gynecol 2000;183:1468–1474.
  • Speiser PW, New MI, White PC. Molecular genetic analysis of nonclassic steroid 21-hydroxylase deficiency associated with HLA-B14 DR1. N Engl J Med 1988;319:19–23.
  • Dondi E, Cuccia M, Keller E, Martinetti M, Larizza D, Albert ED. Molecular analysis of CYP21B gene mutations carried on HLA-B14 positive haplotypes. Eur J Immunogen 1994;21:341–350.
  • Bachega TASS, Billerbeck AEC, Marcondes JAM, Madureira G, Arnhold IJP, Mendonca BB. Influence of different genotypes on 17-hydroxyprogesterone levels in paients with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin Endocrinol 2000;52:601–607.
  • Azziz R, Rafi A, Smith BR, Bradley EL, Zacur HA. On the origin of the elevated 17-hydroxyprogesterone levels after adrenal stimulation in hyperandrogenism. J Clin Endocrinol Metab 1990;70:431–436.
  • Vermesh M, Silva PA, Rosen GF, Vijod AG, Lobo RA. Effects of androgen on adrenal steroidogenesis in normal women. J Clin Endocrinol Metab 1988;66:128–130.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.